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Phosphodiesterase 3B (PDE3B) is an important component of insulin and cAMP-dependent signalling pathways. In order to study
phosphorylation of PDE3B, we have used an adenoviral system to express recombinant flag-tagged PDE3B in primary rat adipocytes and H4IIE
hepatoma cells. Phosphorylation of PDE3B after treatment of cells with insulin, cAMP-increasing agents, or the phosphatase inhibitor, calyculin A
was analyzed by two-dimensional tryptic phosphopeptide mapping and mass spectrometry. We found that PDE3B is multisite phosphorylated in
adipocytes and H4IIE hepatoma cells in response to all these stimuli. Several sites were identified; serine (S)273, S296, S421, S424/5, S474 and
S536 were phosphorylated in adipocyte as well as H4IIE hepatoma cells whereas S277 and S507 were phosphorylated in hepatoma cells only.
Several of the sites were phosphorylated by insulin as well as cAMP-increasing hormones indicating integration of the two signalling pathways
upstream of PDE3B, maybe at the level of protein kinase B.
© 2007 Elsevier B.V. All rights reserved.Keywords: PDE3B; Phosphorylation; Adipocyte; Hepatocyte; Insulin; cAMP1. Introduction
Cyclic nucleotide phosphodiesterases (PDEs) constitute
eleven families of cAMP and cGMP hydrolyzing enzymes.
PDE3B, one of two members in the PDE3 family, is highly
expressed in brown and white adipose tissue, liver and
pancreatic-β cells [1], and has been shown to have an important
role in the regulation of lipid and glucose metabolism in intact
cells as well as in vivo [2]. Although it is well established that
insulin as well as hormones that increase cAMP induce
activation of PDE3B in adipocytes and hepatocytes, mechan-
isms involved in the regulation of PDE3B have been studied
mainly in adipocytes. Thus, insulin stimulation of adipocytes
induces serine phosphorylation and activation of PDE3B which
involves tyrosine phosphorylation of insulin receptor substrates⁎ Corresponding author. Tel.: +4646 2228587; fax: +4646 2224022.
E-mail address: rebecka.lindh@med.lu.se (R. Lindh).
1 Contributed equally to this work.
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.01.010(IRS), activation of phosphoinositide 3-kinase (PI3K), and
generation of phosphatidylinositol 3,4/3,4,5 phosphate [3,4].
Downstream of PI3K, protein kinase B (PKB) appears to be an
important insulin-stimulated kinase phosphorylating PDE3B
[5–7]. Stimulation of adipocytes with isoproterenol and other
cAMP-increasing agents also leads to serine phosphorylation
and activation of PDE3B which is believed to be important in
feedback regulation of cAMP.
Regarding the identity of sites phosphorylated in PDE3B in
response to hormone stimulation of cells, the results from
adipocytes are incomplete and partly contradictory, and there is
to our knowledge no information on the phosphorylation of the
135 kDa PDE3B in hepatocytes. Two-dimensional tryptic
phosphopeptide mapping of endogenous PDE3B from primary
rat adipocytes identified S302 (corresponding to S296 in
mouse) as a major site phosphorylated in adipocytes in response
to both insulin and isoproterenol [8]. In another study using a
site-directed mutagenesis approach in 3T3-L1 mouse adipo-
cytes, S273 was shown to be important for insulin-mediated
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important for isoproterenol but not insulin-mediated activation
of the enzyme [7]. The small amount of phosphorylated
protein/peptide that can be obtained from endogenous
phospho-PDE3B is a limiting factor for detailed studies on
PDE3B phosphorylation. In this work we have developed and
used an adenoviral system to express flag-tagged PDE3B in
primary rat adipocytes and cultured H4IIE hepatoma cells. We
show that PDE3B in adipocytes as well as hepatocytes is
subjected to multisite phosphorylation, and a number of new
sites have been identified.
2. Materials and methods
2.1. Material
Dulbecco's modified Eagle medium (DMEM) and foetal calf serum (FBS)
were obtained from GIBCO BRL (Praisley, UK); 32Pi was purchased from
Amersham Bioscience (Little Chalfont, UK); anti-flag M2 affinity gel and
bovine serum albumin (BSA) from Sigma (Saint Louis, USA); calyculin A from
Alexis Biochemicals (Läufelfingen, Switzerland); sequencing grade modified
trypsin from Promega (Madison, USA); C13E12 from Berol Kemi AB
(Stenungssund, Sweden); insulin from Novo Nordisk (Copenhagen, Denmark);
BCA protein assay reagent from Pierce (Rockford, USA); H4IIE rat hepatoma
cells from ATCC (Manassas, USA); and Sprague–Dawley rats from B&K
Universal (Stockholm, Sweden). OPC3911 was a kind gift from Otsuka America
Pharmaceutical (Rockville, USA). The β-galactosidase adenovirus was kindly
provided by Drs. C.B. Newgard and H. Mulder and the flag-tagged PDE3B
adenovirus was produced as described by L. Harndahl et al. [9]. The PDE3B
antibodies were polyclonal and raised in rabbit against the peptide
CGYYGSGKMFRRPSLP from PDE3B.
2.2. Preparation, infection, stimulation and 32Pi labeling of primary
rat adipocytes
Adipocytes were prepared from epididymal adipose tissue of 36- to 43-day-
old male Sprague–Dawley rats according to Rodbell [10], with modifications
according to Honnor et al. [11]. The cells (12.5% cell suspension) were
suspended in DMEM with 5% FBS and 0.5% BSA and infected with β-
galactosidase adenovirus (Adβ-gal, 5.0×107 virus/ml) or murine flag-tagged
PDE3B adenovirus (AdPDE3B, 6.5×107 virus/ml) for 6 or 14 h at 37 °C. The
infected cells were washed and subjected to subcellular fractionation as
described by Simpson et al. [12] with modifications as described by Goransson
et al. [13], or resuspended in Krebs–Ringer medium pH 7.5, 25 mM HEPES,
200 nM adenosine, 2 mM glucose and 1% BSA (0.3–1.5 ml 10% cell
suspension). For 32Pi labeling, the medium was supplemented with 2.5% BSA,
600 μMKH2PO4 (2–4 ml 10% cell suspension) and
32Pi (0.2–0.5 mCi/ml). The
resuspended cells were stimulated at 37 °C, homogenized at room temperature in
0.6–2 ml of buffer A consisting 50 mM TES, pH 7.4, 250 mM sucrose, 1 mM
EDTA, 0.1 mM EGTA, antipain (10 μg/ml), leupeptin (10 μg/ml) and pepstatin
A (1 μg/ml), and placed on ice. Homogenates from labeled cells was centrifuged
at 175,000×g for 1 h at 4 °C and the fat cake and supernatant removed. The
crude membrane fraction was rehomogenized in 0.75–1 ml buffer A
supplemented with 1% C13E12, 80 mM NaF and 80 mM NaCl, put on ice for
1 h and centrifuged (8000×g, 10 min, 4 °C). The supernatant was mixed with
50–70 μl packed anti-flag M2 affinity agarose for 2.5–4 h at 4 °C. The gel was
washed five times with 500 μl of buffer A and flag-PDE3B was either eluted by
boiling the gel for 15 min with 90 μl of buffer A supplemented with 1.6% SDS
and 1 mg/ml BSA, or by adding trypsin as described below.
2.3. Preparation, infection, stimulation and 32Pi labeling of H4IIE
hepatoma cells
H4IIE hepatoma cells were propagated and maintained in DMEM medium
supplemented with 10% FBS, and 2 mM glutamine. The cells (1×107 cells in100 mm petri dishes) were infected with AdPDE3B (2×109 virus/ml) or Adβ-
gal (2×109 virus/ml) in DMEM medium without serum for 3 h before the
medium was supplemented with 10% FBS and cultured for another 45 h. After
infection, H4IIE cells were washed 3 times with PBS and incubated for 16 h in
DMEM without serum. The cells were then incubated for 2 h with serum-free
DMEM containing 300 μM KH2PO4 and
32Pi (0.2 mCi/ml), before stimulation.
The H4IIE cells were suspended in 3–4 ml 50 mM HEPES (pH 7.5), 250 mM
sucrose, 1 mMEDTA, 10 mM pyrophosphate, 5 mMNaF, 100 mMNaCl, 1 mM
Na3VO4, Roche protease inhibitor cocktail, and homogenized in a Dounce
homogenizer containing 1% Nonidet P-40. Homogenates were sonicated (1×5
pulses, output 2, 30% cycle) at 4 °C, kept on a rotator for 30 min at 4 °C, and
centrifuged (12,000×g, 20 min, 4 °C) to remove insoluble material. Protein was
measured using BCA protein assay reagent with BSA as standard. Approxi-
mately 3–8 mg proteins isolated from H4IIE cells infected with Adβ-gal or
AdPDE3B were immunoprecipitated with 50 or 150 μl of anti-flag M2 affinity
gel overnight. The precipitate was washed four times and eluted by boiling in
Laemmli sample buffer for further analysis.
2.4. Trypsinization, peptide extraction, and two-dimensional (2D)
phosphopeptide mapping of tryptic 32P-labeled flag-PDE3B from
primary rat adipocytes and H4IIE hepatoma cells
Adipocyte 32Pi-labeled PDE3B bound to anti-flag M2 affinity gel was
trypsinized at 37 °C for 16 h with shaking in 210 μl containing 48 mM
ammonium bicarbonate, 48 μM HCl and 4.8 μg/ml trypsin. The tryptic digests
were removed and dried by vacuum centrifugation. Gel bands of ∼1.5×6 mm
containing approximately 200–300 ng immunoprecipitated PDE3B from
H4IIE hepatoma cells were washed with HPLC grade water, HPLC grade
methanol and finally with 50% acetonitrile (ACN) (750 μl/tube with gentle
shaking for 2–3 min). The gel pieces were dried for 30 min in a SC 110A
SpeedVac® Plus (ThermoSavant) and incubated in 80 μl containing 100 mM
ammonium bicarbonate and 5.0 μg/ml trypsin at 37 °C. After 3 h, additional
trypsin was added to the final concentration of 9.0 μg/ml, and the gel pieces
were incubated for 12 h at 37 °C. The digest solution was transferred to a
polypropylene tube and extracted with 60 μl of 0.1% TFA and 50% ACN for
30 min at 37 °C with shaking. The extracts were evaporated under vacuum
and analyzed with MS/MS analysis after nano-liquid chromatography
separation or subjected to 2D tryptic phosphopeptide mapping exactly as
described in [8].
2.5. Mass spectrometry (MS) analysis of phosphorylated adipocyte
PDE3B peptides from 2D tryptic phosphopeptide maps
Phosphopeptides from the 2D tryptic phosphopeptide maps (originating
from 12 ml 10% adipocyte cell suspension) were scraped out and mixed with
200 μl 20% ACN and 0.1% formic acid for 10 min and subjected to an
ultrasonic bath for 10 min. The samples were centrifuged (40,000×g for
20 min) and the supernatant vacuum centrifuged to complete dryness. The
dried peptide fractions were dissolved in 8 μl 1% formic acid in H2O and
6 μl were subjected to High Performance Liquid Chromatography (HPLC)-
tandem MS (MS/MS) analysis. In some cases, the remaining 2 μl was mixed
with 1 μl MALDI matrix (5 mg alpha-cyano-4-hydroxycinnamic acid/ml in
50% ACN, 0.1% triflouroacetic acid) and spotted on MALDI target plates.
During HPLC-MS/MS the peptides were separated on an Atlantis dC18
NanoEase column (0.075×150 mm, 3 μm particle size) connected to a
CapLC pump coupled to a Q-ToF Ultima mass spectrometer (Waters UK
Ltd., Manchester, UK), using a 40-min linear gradient from 6% ACN to 55%
ACN in H2O, 0.1% formic acid with a flow rate of 0.25 μl/min. The samples
spotted on MALDI target plates were analyzed using a Finnigan LTQ linear
ion trap mass spectrometer equipped with a vMALDI ion source controlled
by Excalibur 1.4 (Thermo Electron Corporation, San José, CA, USA). The
instrument was set to perform an MS survey scan (m/z 900–2000) followed
by MS/MS scans of the 15 most abundant ions in each sample and to
automatically switch to MS3 when detecting a neutral loss of 98 Da, thus
performing both MS/MS and MS3 on potential phosphopeptides. The
acquired MS/MS data from the Q-Tof Ultima was converted to PKL files
using ProteinLynx 2.2 (Waters UK Ltd., Manchester, UK). The PKL files
Fig. 1. Expression and subcellular localization of flag-PDE3B in rat adipocytes.
Primary rat adipocytes were incubated for 6 h with β-galactosidase adenovirus
(Adβ-gal) or flag-PDE3B adenovirus (AdPDE3B), homogenized, and analyzed
either by immunoblotting (20 μg protein=2.7 μl PCV/lane) using anti-PDE3B
antibodies (A) or by measuring PDE3 activity (B) (n=7). (C) Primary rat
adipocytes were infected for 14 h with Adβ-gal or AdPDE3B, and subjected to
subcellular fractionation before PDE3 activity was measured (n=4). PCV;
packed cell volume, results are shown as mean±SEM.
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tolerance for the precursor ion mass was set to 0.2 Da and the tolerance for
the fragment ion mass was set to 0.1 Da. The data from the LTQ were
processed using Bioworks Browser 3.2 (Thermo Electron Corporation, San
José, CA, USA) and searched using the Sequest search algorithm
incorporated in Bioworks Browser. The tolerance for both the precursor
and fragment ion masses was set to 1 Da. All searches were performed
against the Mus musculus subset of the NCBInr database, using cysteic acid
and methionine sulfone as constant modification and phosphorylation of
serine, threonine and tyrosine as variable modifications. The MS/MS spectra
of identified phosphopeptides were then inspected manually to see if the
identification was correct and to ensure correct assignation of phosphorylation
sites.
2.6. MS analysis of flag-PDE3B extracted peptides from H4IIE
hepatoma cells
Peptide extracts from flag-PDE3B isolated from H4IIE hepatoma cells were
analyzed using a Micromass Q-TOF Ultima Global (Micromass, Manchester,
UK) in electrospray mode interfaced with an Agilent HP1100 CapLC (Agilent
Technologies, Palo Alto, CA) prior to the mass spectrometer. Five to eight
microliters of each digest was loaded onto a Vydac C18 MS column
(100×1.5 mm; Grace Vydec, Hesperia, CA) and chromatographic separation
was performed at 0.1 ml/min using the following gradient: 0–10% B over 5 min;
gradient from 10–40% B over 60 min; 40–95% B over 5 min; 95% B held over
5 min (solvent A: 0.2% formic acid in water; solvent B: 0.2% formic acid in
ACN). Data were processed using the MassLynx software package (version 3.5)
to generate peak list files prior to in-house licensed Mascot 1.8 search at http://
biospec.nih.gov (MatrixScience Ltd., London, UK). For ESI-MS/MS data, a
tolerance of 1.0 Da was chosen for fragments. The combined NCBInr database
was searched with species restriction of mammalia. Carbamidomethyl (C),
oxidation (M), phospho (ST) and phospho (Y) were chosen as variable
modifications.
2.7. Additional analytical procedures
Homogenates from adipocytes and flag-PDE3B immunoprecipitates from
32Pi-labeled adipocytes and H4IIE hepatoma cells were boiled in Laemmli
sample buffer and subjected to sodium dodecyl sulphate-polyacrylamide
electrophoresis (SDS-PAGE), 7–8% acrylamide. The gel was either stained
with Simply Blue™ safe stain (Invitrogen) for 15 min or analyzed by digital
imaging (Fuji FLA-3000, Fuji Inc., Tokyo, Japan) for 32Pi detection. The
proteins were in some experiments electrotransferred to hybond-C membranes
and incubated with PDE3B antibodies as described previously [14]. PDE3
activity and lipolysis were measured as previously described [15,16], in
duplicate. The statistical significance of differences was counted using a paired
Student's t-test. Results are presented as mean±standard error of the mean
(SEM).3. Results
3.1. Characterization of recombinant PDE3B overexpressed in
primary rat adipocytes and H4IIE hepatoma cells
Incubation of primary rat adipocytes with flag-PDE3B
adenovirus (AdPDE3B) (6 or 14 h) resulted in overexpression
of PDE3B (10- or 25-fold) compared to cells incubated with
β-galactosidase adenovirus (Adβ-gal) (Figs. 1A–C). Over-
expression of PDE3B in H4IIE hepatoma cells after AdPDE3B
infection (48 h) was 50- to 100-fold (Figs. 3A, B). The re-
combinant PDE3B was characterized with regard to location,
regulation and biological effects. Adipocytes expressing flag-
PDE3B were subjected to subcellular fractionation, and as
seen in Fig. 1C recombinant and endogenous PDE3B (fromadipocytes infected with Adβ-gal) showed identical distribu-
tion between the different subcellular compartments. Adipo-
cytes and H4IIE cells expressing flag-PDE3B were stimulated
with insulin, cAMP-increasing agents (forskolin, isoproterenol
or/and OPC3911) or a phosphatase inhibitor (calyculin A),
and PDE3 activity was measured in the homogenates
(endogenous PDE3B in adipocyte and H4IIE cells constituted
10% and 1% of total PDE3 activity, respectively, in all
conditions). As shown in Figs. 2A and 3A flag-PDE3B was
activated both in adipocytes and H4IIE cells stimulated with
the different agents, as is the case for endogenous PDE3B
[17–20]. For the analysis of PDE3B phosphorylation in
adipocytes and H4IIE cells expressing flag-PDE3B, cells were
incubated with 32Pi, and flag-PDE3B was immunoprecipitated
using anti-flag M2 affinity gel. As shown in Figs. 2B and 3C,
insulin, cAMP-increasing agents and calyculin A increased
phosphorylation of flag-PDE3B as compared to non-stimu-
lated adipocytes and H4IIE cells. This has previously been
shown for endogenous PDE3B in adipocytes [8,18,19], but to
Fig. 2. Phosphorylation and activation of flag-PDE3B in rat adipocytes in
response to insulin, isoproterenol, OPC3911 and calyculin A. Isolated
primary rat adipocytes expressing flag-PDE3B were incubated with (B) or
without (A) 32Pi before stimulation with 2 nM insulin (Ins) for 10 min,
300 nM isoproterenol (Iso) for 10 min, 10 μM OPC3911 (OPC) for 20 min,
10 μM OPC for 20 min plus 300 nM Iso for the last 10 min, 200 nM
calyculin A (CalA) for 30 min or without stimuli (Ctrl). (A) The cells were
homogenized and PDE3 activity measured (n=8, from the left p<0.023,
p<0.048, p<0.007, p<0.006 and p<0.003). (B) Flag-PDE3B was immuno-
precipitated with anti-flag agarose and subjected to SDS-PAGE and
autoradiography. One representative gel is shown; quantification of the
bands was made using the Fuji LAS 2000 Plus system (lower panel of (B)).
The ratios are presented as fold increase in comparison to control, mean±
SEM (n=7 except for OPC and CalA n=3, from the left p<0.0023,
p<0.043, p<0.14, p<0.0077, p<0.035).
Fig. 3. Phosphorylation and activation of flag-PDE3B inH4IIE hepatoma cells in
response to insulin, forskolin or calyculin A. H4IIE hepatoma cells were infected
with AdPDE3B or Adβ-gal for 48 h. Cells were incubated with or without
100 nM insulin (Ins) for 10min, 100 μMforskolin (Forsk) or 100 nM calyculin A
for 15 min and then homogenized. (A) PDE3 activity (mean±SEM, n=5,
p<0.001) was measured in the homogenates. (B) Flag-PDE3B was immuno-
precipitated with anti-Flag agarose. After SDS-PAGE, the gel was stained with
Simply BlueTM (Invitrogen) to detect the 135 kDa PDE3B protein. (C) H4IIE
cells were incubated with 32Pi (200 μci/ml) for 120 min at 37 °C before
stimulation with insulin, forskolin or calyculin A. After PDE3B immunoisolation
one portion was used for SDS-PAGE and detection of 32P-phosphorylated
PDE3B and another portion for SDS-PAGE and immunoblot analysis.
Fig. 4. PDE3B overexpression in rat adipocytes lowers basal lipolysis, and
enhances insulin-induced inhibition of lipolysis. Isolated primary rat adipocytes
infected with AdPDE3B or Adβ-Gal adenoviruses for 6 h were incubated with
30 nM isoproterenol (Iso) alone or together with 0.1–0.3 nM insulin (Ins), or
without any stimuli (Ctrl) as indicated. Glycerol release was determined after
30 min (mean±SEM, n=7, p<0.001).
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Finally, lipolysis was measured in AdPDE3B and Adβ-gal
infected primary rat adipocytes to investigate the ability of flag-
PDE3B to mediate regulation of lipolysis. As shown in Fig. 4,
lipolysis was lower in AdPDE3B infected cells as compared to
Adβ-gal infected cells. Furthermore, in AdPDE3B infected
cells insulin-induced inhibition of isoproterenol mediated
lipolysis was enhanced. Thus, at 0.1 nM insulin isoproterenol-
induced lipolysis was lowered by 24.0±7.1% and 40.9±4.2%
(p=0.0014) in Adβ-gal and AdPDE3B infected cells, respec-
tively. At 0.3 nM insulin the lowering of lipolysis was 47.5±
7.3% and 55.8±5.1% (p=0.058) in Adβ-gal and AdPDE3B
infected cells, respectively. In the following, flag-PDE3B
phosphorylated in response to different agents in adipocytes
and H4IIE cells were used as starting material for studies of
PDE3B phosphorylation.3.2. PDE3B is subjected to multisite phosphorylation in
response to insulin, cAMP-increasing agents and calyculin A in
primary rat adipocytes and H4IIE hepatoma cells
As a first step to study the sites phosphorylated in PDE3B
in adipocytes and hepatoma cells, we generated 2D tryptic
588 R. Lindh et al. / Biochimica et Biophysica Acta 1773 (2007) 584–592phosphopeptide maps of flag-PDE3B phosphorylated in
response to different stimuli. Primary rat adipocytes and H4IIE
cells expressing flag-PDE3B were labeled with 32Pi and treated
with insulin, cAMP-increasing agents, or calyculin A. Deter-
gent-treated membrane fractions were applied to an anti-flagM2
affinity gel. After extensive washing flag-PDE3B attached to the
anti-flag M2 affinity gel was subjected to trypsin digestion
(adipocyte derived material) or eluted from the column (H4IIE
cells and adipocyte derived material). Eluted PDE3B was
subjected to SDS-PAGE, detected by autoradiography (seen in
Figs. 2B and 3C), cut out and digested with trypsin. The PDE3B
tryptic phosphopeptides (tPP) from both adipocytes and H4IIE
cells were separated in two dimensions using thin layer
electrophoresis (TLE) and thin layer chromatography (TLC).
Several tPPs denoted tPP1–13 were generated from the
adipocyte PDE3B (Figs. 5A–E) and H4IIE cell PDE3B (Figs.
5G–J) in response to the different agents. Fig. 5F represents a
summary of 40 adipocyte and H4IIE PDE3B maps showing a
merged picture of the tPPs reproducibly observed with the
different agents. tPP2, tPP3 and tPP8–12 appear to be present in
all maps from adipocytes independent of the activating stimuli.
On the other hand, tPP1, which is present after insulin as well as
isoproterenol ±OPC3911 stimulation, is not present after
calyculin A stimulation. Furthermore, tPP7 is present only in
maps from adipocytes stimulated with isoproterenol±OPC3911,
and tPP4–6 and tPP13 appear only in maps from calyculin A
stimulated cells. When comparing the two cell types, tPP2–6,Fig. 5. Multisite phosphorylation of PDE3B in rat adipocytes and H4IIE hepatoma
Isolated primary rat adipocytes expressing flag-PDE3Bwere labeled with 32Pi and inc
10 μMOPC3911 for 20 min together with 300 nM isoproterenol (Iso+OPC) during th
Flag-PDE3B was immunoisolated before trypsin digestion. (G–J) H4IIE hepatoma ce
100 nM insulin (Ins), 100 μM forskolin (Forsk), 100 nM calyculin A (Cal A) or wit
extracted and digested with trypsin. All of the tryptic digests (loaded on the down le
(TLE, 2000 V, 35 min) and thin layer chromatography (TLE, isobutyric buffer); digita
from all maps are summarised and denoted 1–13. Representative maps are shown ftPP9–10 and tPP13 appear to be present in maps from
adipocytes as well as H4IIE cells. The major differences
between the adipocyte and H4IIE PDE3B maps are the lack of
tPP1, tPP7 and tPP8 in the H4IIE maps. The lack of tPP1 can be
explained by the fact that the tPP corresponding to tPP1 in
PDE3B H4IIE maps contains one additional phosphorylation
and two additional arginine (see MS/MS results below) which
gives the peptide a different mobility during the TLE and TLC.
Unfortunately we were not able to locate the H4IIE tPP
corresponding to adipocyte tPP1 in the H4IIE maps. In the
PDE3B maps generated from H4IIE cells, forskolin, which
increases cAMP in the cell, and insulin interestingly produced
similar PDE3B phosphorylation patterns (Figs. 5I vs. H).
3.3. Identification of sites phosphorylated in PDE3B in
primary rat adipocytes and in H4IIE hepatoma cells
In order to identify sites phosphorylated in PDE3B from
primary rat adipocytes, we scraped out tPPs from 2D tPP maps
of flag-PDE3B, in most cases originating from calyculin A or
isoproterenol+OPC3911 stimulated adipocytes (Figs. 5D and
E). The tPPs were identified using mass spectrometry (HPLC-
MS/MS) as described in Materials and methods. To this end six
out of the 13 tPPs summarised in Fig. 5F have been identified
(Table 1). All identifications were performed using spectra from
the Q-ToF Ultima. In most cases the phosphorylation site(s) of
each peptide was unambiguously assigned. Flag-PDE3B tPP1–cells in response to insulin, cAMP-increasing agents and calyculin A. (A–E)
ubated with 2 nM insulin (Ins) for 10 min, 300 nM isoproterenol (Iso) for 10 min,
e last 10 min, or 200 nM calyculin A (Cal A) for 20 min or without stimuli (Ctrl).
lls expressing flag-PDE3B were labeled with 32Pi and incubated for 15 min with
hout stimuli (Ctrl). Flag-PDE3B was immunoisolated, subjected to SDS-PAGE,
ft corner of each map in the figure) were subjected to thin layer electrophoresis
l imaging was then performed to detect 32P. (F) The tryptic phosphopeptides (tPP)
or each condition (n=6 for A–E, n=2 for G–J).
Table 1
Identification of sites phosphorylated in mouse PDE3B expressed in primary rat
adipocytes
Spot Sequence Residues
(start–end)
Phospho-serine
(S)
tPP1 pSSCaVSLGESAAGYYGSGK 273–290 S273
tPP2 RPpSLPCalSR 294–302 S296
tPP3 RSpSGASSLLTNEHCaSR 419–434 S421
tPP4 RSpSGAp[SS]LLTNEHCaSR 419–434 S421, S424/5
tPP5 SSpSVSLTHHAGLR 472–484 S474
tPP6 SLGpSVSSAADFHQYLR 533–548 S536
Tryptic phosphopeptides from Flag-PDE3B originating from adipocytes
stimulated with calyculin A or isoproterenol+OPC3911 were extracted from
the 2D phosphopeptide maps and identified. Observed ions used for the
assignation of phosphorylation site(s) (ion designation-mass); tPP1: tPP1: b2-
255.04, b2Δ98-157.06, b3-406.05, b3Δ98-308.05; tPP2: y2-262.14, b3-323.17;
tPP3: b2-244.14, b*2-227.11, b°2-226.12, a2-216.14, a*2-199.12, a°2-198.13;
tPP4: b2-244.14, b*2-227.11, b°2-226.12, a2-216.14, a*2-199.12, a°2-198.13
y2–y3–y4–; tPP5: b2-175.06, b*2-158.06, b°2-157.06, a2-147.07; tPP6: MS2
y11-1294.5, y12-1393.4 MS3 y10-1207.7, y13-1462.5, y14-1519.7.
Fig. 6. PDE3B phosphorylation and putative kinases involved. (A) The
phosphorylation sites identified are localized within the regulatory domain of
PDE3B. Two of the serines (S) have been identified only in hepatoma cells (°).
NHR (N-terminal hydrophobic region) 1 contains 5 helical transmembrane
regions and NHR2 a small hydrophobic region. (B) Sequences surrounding the
phosphorylated sites are shown. Some of the sequences contain consensus
sequences for phosphorylation by PKB and PKA, and for binding to 14-3-3
proteins, as indicated.
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5 (peptide phosphorylated on S421 and either S424 or S425),
S474 and S536, respectively (Table 1). As shown in Figs. 5A–
E, S273, S296 and S421 were phosphorylated in response to
stimulation of rat adipocytes with insulin as well as isoproter-
enol±OPC391 whereas S424/5, S474 and S536 were phos-
phorylated mainly in response to calyculin A.
To identify sites phosphorylated in hepatocyte PDE3B, flag-
PDE3B expressing H4IIE cells were stimulated with insulin or
calyculin A and the recombinant enzyme was immunoisolated
with anti-flag M2 affinity gel and subjected to SDS-PAGE. The
135 kDa PDE3B band detected after staining with Simply
Blue™ safe stain (Fig. 3B) was cut out and subjected to in-gel
trypsin digestion. Digested PDE3B was analyzed using mass
spectrometry (HPLC-MS/MS) as described in Materials and
methods. As shown in Table 2, insulin induces phosphorylation
of S273, S277, S296 and S421. In addition to those sites
calyculin A induces phosphorylation of S474, S507 and S536.
4. Discussion
In this work we have identified a number of new PDE3B
phosphorylation sites, all of which are localized in theTable 2
Identification of sites phosphorylated in mouse PDE3B expressed in H4IIE hepatom
Phospho-serine (S) Sequence
S273, S277 RRpSSCVpSLGESAAGYYGSGK
S296 RPpSLPCISR
S421 RSpSGASSLLTNEHCSR
S474 SSpSVSLTHHAGLR
S507 RAGALPSHSLLNSSSHVPVSAGpSLTNR
S536 SLGpSVSSAADFHQYLR
Flag-PDE3B from H4IIE hepatoma cells infected with AdPDE3B and stimulated with
isolated by anti-flag agarose, and subjected to SDS-PAGE. The 135 kDa band seen
Average total sequence coverage for flag-PDE3B after tryptic analysis were 28, 35 an
used for the assignation of phosphorylation site(s) (ion designation-mass); S273, S27
313.16; S474: b2-175.07, b3-244.09; S507: y*3-373.18, y6-629.34; S536: b3-258.1regulatory domain of the enzyme (Fig. 6A). The results
presented extensively extend the knowledge of PDE3B
phosphorylation in adipocytes and are also, to our knowledge,
the first report on phosphorylation of the 135 kDa PDE3B in
hepatocytes (Table 2). Previous studies on endogenous PDE3B
phosphorylated in adipocytes indicated multisite phosphoryla-
tion of the enzyme; however, identification of several of the
sites was not possible due to the limited amount of
phosphorylated PDE3B [8,19]. In order to generate sufficient
amount of material for PDE3B site analysis, in this study mouse
PDE3B was overexpressed in adipocytes as well as rat H4IIE
cells. Importantly, the overexpressed PDE3B was carefully
characterized with regard to localization, regulation and
function. Thus, overexpressed PDE3B was localized to the
same subcellular compartment as endogenous, i.e., in the
plasma membrane and high-density membrane fraction. Other
important arguments with regard to the relevance for our model
are that the overexpressed PDE3B is activated in response toa cells
Residues (start–end) ins Cal A
271–290 X X
294–302 X X
419–434 X X
472–484 – X
485–511 – X
533–548 – X
100 nM insulin (Ins) for 10 min or 100 nM calyculin A (CalA) for 15 min were
in Fig. 3C was subjected to trypsin digestion and the peptides were identified.
d 44% in Ctrl, Ins and CalA treated samples respectively (n=3). Observed ions
7: b++6-364.68, y6-674.31; S296: b3-323.18, y6-745.40; S421: b2-244.14, b3-
8, b4-345.18.
590 R. Lindh et al. / Biochimica et Biophysica Acta 1773 (2007) 584–592various stimuli in the same manner as the endogenous PDE3B
and mediates regulation of lipolysis. Finally, we get similar
results from both adipocytes and H4IIE cells regarding the
phosphorylation of the overexpressed PDE3B which also
support the relevance for the sites identified.
Multisite phosphorylation of PDE3B suggests complex and
intricate regulatory mechanisms involving phosphorylation
dependency with regard to docking with other proteins, control
of catalytic activity, subcellular localization, and protein
degradation. With regard to activity control, phosphorylation
of S273 was previously shown to be important for insulin-
induced activation whereas S296 was shown to be important for
isoproterenol-induced activation of PDE3B in 3T3-L1 adipo-
cytes using a site-directed mutagenesis strategy [7]. In the
present study, however, we show that both S273 and S296 are
phosphorylated in response to insulin as well as isoproterenol.
In agreement with these results, S302 (corresponding to S296 in
mouse) in endogenous PDE3B was previously shown to be
phosphorylated in response to insulin as well as isoproterenol
stimulation of primary rat adipocytes [8]. As shown in the
present work, insulin (Table 2) as well as forskolin induced
phosphorylation of S296 in H4IIE hepatoma cells (Fig. 5I),
indeed supporting an important role for this site as a target for
insulin as well as cAMP action. Also in 3T3-L1 adipocytes
S296 as well as S273 seem to be important targets for insulin-
induced PDE3B phosphorylation. Thus, Onuma et al. [21] have
demonstrated insulin-dependent interactions between PDE3B
and 14-3-3 proteins in 3T3-L1 adipocytes, which was disrupted
by adding PDE3B peptides phosphorylated at S296 or S273. All
together these results support the importance of both S273 and
S296 PDE3B phosphorylation in response to either insulin or
isoproterenol in primary rat as well as mouse 3T3-L1
adipocytes. With regard to PDE3B interactions in addition to
14-3-3, we have shown insulin-dependent interactions in 3T3-
L1 adipocytes between phosphorylated PDE3B and a number of
insulin signalling components such as IRS-1, PI3K p85 and
PKB (Ahmad et al., unpublished data). PDE3B has also been
shown to interact with the insulin receptor in a hormone-
dependent manner in human adipocytes [22] and in a hormone-
insensitive manner with PI3Kγ in mouse heart [23], caveolae in
rat adipocytes [14], and a 47 kDa protein of unknown function
in 3T3-L1 adipocytes [24,25]. The interactions of PDE3B with
several other proteins both in a hormone sensitive and hormone-
insensitive manner are probably very important. We suggest that
PDE3B is regulated by an intricate system of phosphorylations
some of which are activity-controlling whereas others regulate
interactions with other proteins.
Exactly which kinases are responsible for the phosphoryla-
tions of PDE3B is not known. The finding that some of the sites
in adipocytes and hepatocytes, respectively, can be phosphory-
lated in response to a broad range of stimuli indicate integration
of signalling pathways upstream of PDE3B, maybe at the level
of PKB. Indeed, PKB, which has been suggested to be a PDE3B
kinase, is known to be phosphorylated/activated both by insulin,
β-adrenergic agonists and phosphatase inhibitors in adipocytes
[26–28], supporting a role for PKB in mediating, at least partly,
the isoproterenol effect on PDE3B. This could thus give amechanistic explanation to why isoproterenol and insulin
induce phosphorylation of a set of sites that are the same. On
the other hand, isoproterenol, but not insulin, induces the
appearance of tPP7 in adipocyte PDE3B maps indicating the
presence also of isoproterenol-dependent but PKB-independent
control of PDE3B phosphorylation. Unfortunately, we have not
been able to identify tPP7 (radio sequencing indicates that
amino acid 3 and/or 4 is phosphorylated). We did not detect
tPP7 in PDE3B maps from forskolin stimulated H4IIE cells
which represents one of the few differences when comparing
sites phosphorylated in PDE3B in adipocytes and hepatocytes.
When performing a search for possible PKB phosphorylation
sites within PDE3B using Scansite 2.0, which utilizes short
sequence motifs to predict possible cell signalling interactions
based on phage display and oriented peptide library [29], we
found, with medium stringency, four PKB phosphorylation sites
with similar scores S273, S296, S474 and S378. Thus, three out
of four sites localized within a consensus sequence for
phosphorylation by PKB were identified in this work namely
S273, S296 and S474 (Fig. 6B).
Although one hypothesis is that isoproterenol mediates its
effect via PKB at least to some extent, PDE3B could also be a
direct target for PKA, a kinase previously shown to phosphor-
ylate rat adipocyte PDE3B on S427 (corresponding to S421 in
mouse) in vitro [30]. S421 is a site identified also in this work
(phosphorylated by all stimuli) and is situated in a typical PKA
phosphorylation consensus sequence (Fig. 6B). In addition,
three other sites situated in consensus sequences for phosphor-
ylation by PKA appeared when performing a search using
Scansite 2.0, namely S273, S274 and S296. Thus, S273 as well
as S296 are potential targets for PKB as well as PKA catalyzed
phosphorylations, which is interesting in the context of
interplay between insulin and isoproterenol mediated regulation
of PDE3B. In this perspective one should also have in mind that
β-adrenergic agonists can mediate cAMP-dependent as well as
cAMP-independent signalling events and cAMP-dependent
signalling can be PKA-dependent as well as PKA-independent,
the latter via Epac (GTP exchange factor activated by cAMP).
With regard to S277 (H4IIE cells), S507 (H4IIE cells),
S424/425 (adipocytes and H4IIE-tPP4), and S536 (adipocytes
and H4IIE cells), kinases and phosphatases involved in
controlling the phosphorylation state of these sites are
completely unknown. We have previously shown that PP2A
has an important role in the phosphorylation and activation of
PDE3B [19]. In this study it is interesting to observe that pre-
treatment of adipocytes and H4IIE cells with calyculin A,
which inhibits PP1 and PP2A [19], generates almost identical
phosphorylation patterns of PDE3B in the two cell types. In a
previous study it was also shown that pre-treatment of rat
adipocytes with okadaic acid (a PP2A inhibitor) and calyculin
A induced slightly different phosphorylation patterns of
endogenous PDE3B which is in agreement with findings
from overexpressed PDE3B (data not shown). Thus, the role
for different phosphatases and kinases in the regulation of
PDE3B phosphorylation will be further evaluated. Finally, we
have not yet been able to identify the sites phosphorylated in
tPP7–13.
591R. Lindh et al. / Biochimica et Biophysica Acta 1773 (2007) 584–592We conclude that PDE3B is subjected to multisite phosphor-
ylation in response to hormones in adipocytes as well as
hepatocytes, which was recently also reported for PDE3A [31].
The elucidation of the regulation of PDE3B phosphorylation is
important as part of understanding the cAMP and insulin
signalling networks in adipocytes and hepatocytes which play a
key role in the regulation of lipolysis, glucose uptake and
lipogenesis in adipocytes and glycogenolysis and glyconeogen-
esis in hepatocytes.
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